Planta Med 2003; 69(5): 429-433
DOI: 10.1055/s-2003-39714
Original Paper
Pharmacology
© Georg Thieme Verlag Stuttgart · New York

Neuroprotective Effects of Hydroxysafflor Yellow A: In Vivo and in Vitro Studies

Haibo Zhu1, 2 , Zhenhua Wang2 , Chengjun Ma2 , Jingwei Tian2 , Fenghua Fu2 , Changling Li3 , Dean Guo3 , E. Roeder4 , Ke Liu2
  • 1Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P. R. China
  • 2School of Pharmacy of Yantai University, Yantai, Shangdong, P. R. China
  • 3School of Pharmaceutical Sciences of Peking University Health Science Center, Beijing, P. R. China
  • 4Pharmaceutical Institute of Bonn University, Bonn, Germany
Further Information

Publication History

Received: August 14, 2002

Accepted: February 22, 2003

Publication Date:
12 June 2003 (online)

Zoom Image

Abstract

Previous work has shown that hydroxysafflor yellow A (HSYA), extracted from Carthamus tinctorius L. markedly extended the coagulation time in mice and exhibited a significant antithrombotic effect in rats. The present study was conducted to demonstrate further its neuroprotective effects on cerebral ischemic injury in both in vivo and in vitro studies. In vivo, male Wistar-Kyoto (WKY) rats with middle cerebral artery occlusion (MCAO) were evaluated for neurological deficit scores followed by the treatment with a single dose of HSYA. Furthermore, the infarction area of the brain was assessed in the brain slices. In vitro, the effect of HSYA was tested in cultured fetal cortical cells exposed to glutamate and sodium cyanide (NaCN) to identify its neuroprotection against neurons damage. The results in vivo showed that sublingular vein injection of HSYA at doses of 3.0 mg/kg and 6.0 mg/kg exerted significant neuroprotective effects on rats with focal cerebral ischemic injury by significantly decreasing neurological deficit scores and reducing the infarct area compared with the saline group, HSYA at a dose of 6.0 mg/kg showed a similar potency as nimodipine at a dose of 0.2 mg/kg. Sublingular vein injection of HSYA at the dose of 1.5 mg/kg showed a neuroprotective effect, however, with no significant difference when compared with the saline group. Results in vitro showed that HSYA significantly inhibited neuron damage induced by exposure to glutamate and sodium cyanide (NaCN) in cultured fetal cortical cells. Noticeably, the neuroprotective action of HSYA on glutamate-mediated neuron injury was much better than that of HSYA on NaCN-induced neuron damage. All these findings suggest that HSYA might act as a potential neuroprotective agent useful in the treatment in focal cerebral ischemia.

Abbreviations

HSYA:hydroxysafflor yellow A

TTC:2,3,5-triphenyltetrazolium chloride

MTT:3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide

DMEM:Dulbecco's modified Eagle medium

FCS:Fetal calf serum

MCAO:middle cerebral artery occlusion

ECA:external carotid artery

ICA:internal carotid artery

LDH:lactate dehydrogenase

NMDA:N-methyl-D-aspartate